Skip to main content
Year archive

Pangen Biotech Inc. — 2026 filings

All 20 regulatory filings released by Pangen Biotech Inc. (222110) in 2026, sourced directly from the official regulator.

20 Filings
2026 Period
2026 filings (20)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-04-24 Korean
[기재정정]사업보고서 (2025.12)
Annual Report FY 2025
2026-04-22 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2026-04-20 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-03-20 Korean
전환가액의조정
Capital/Financing Update
2026-03-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-03-18 Korean
주주총회소집공고
AGM Information
2026-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-03-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-03-09 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-05 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing
2026-02-13 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing
2026-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2026-02-03 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing
2026-01-27 Korean